Clinical Trial Update: A Trial to Evaluate Two Schedules of MS275 in Combination With 5AC in Elderly Patients With Acute Myeloid Leukemia (AML) [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating two schedules of entinostat (MS275) in combination with azacitidine (5-AC) in elderly patients with acute myeloid leukemia; the study i…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Myeloid Leukemia

Drugs mentioned

• 5-Azacytidine (5-azacytidine)
• MS275 (entinostat)

Snippet

Sponsor: Hetty Carraway | Conditions: Acute Myeloid Leukemia | Phase 2 | Status: ACTIVE_NOT_RECRUITING